Headache diary

OTHER4 trials

Sponsors

Avulux, Inc., Helse Nord-Trøndelag HF, Hackensack Meridian Health, Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

Conditions

HeadacheHeadache (Migraine)MigraineMigraine DisabilityMigraine DiseaseMigraine DisorderMigraine HeadacheTension Type Headache

Unknown Phase

Use of the Avulux® Lenses as an Aid in Reducing the Impact of Migraine Headaches

CompletedNCT04341298

Avulux, Inc.Migraine

Start: 2020-04-06End: 2020-08-26Updated: 2023-01-09

BioTenCer: Biofeedback as Preventive Treatment in Tension Type Headache

Not yet recruitingNCT07136740

Helse Nord-Trøndelag HFTension Type Headache

Start: 2025-09-01End: 2027-12-31Target: 300Updated: 2025-08-22

Long-term Atogepant in Real-world Practice

CompletedNCT07699549

Fundación de Investigación Biomédica - Hospital Universitario de La PrincesaHeadache, Headache (Migraine), Migraine +4

Start: 2024-06-01End: 2026-03-01Updated: 2026-07-13

Headache Diary for Migraine Patients

Enrolling by invitationNCT07698249

Hackensack Meridian HealthMigraine

Start: 2025-01-14End: 2029-08-01Target: 50Updated: 2026-07-20

Related Papers

Targeting the intrinsically photosensitive retinal ganglion cell to reduce headache pain and light sensitivity in migraine: A randomized double-blind trial.

2023-05-055 citations